Cystic fibrosis drug Trikafta, Keytruda for lung cancer to be funded [Video]

In 25 sleeps, New Zealanders with cystic fibrosis will be handed a chance at a future, according to a man with the condition, thanks to a landmark decision by Pharmac to fund the powerful drug Trikafta.

“I can’t wait to see what the cystic fibrosis community is going to do with their life,” Ed Lee, said.

“Maybe they’ll be doctors, maybe they’re going to be teachers, maybe they’ll cure cancer. They could be the CEO of a company that’s going to solve the climate crisis. We’ve now given these people a chance to live.”

Pharmac confirmed on Tuesday that Trikafta would be funded for eligible people over the age of 6 from April 1. It also said it would fund two new medicines – pembrolizumab (branded as Keytruda) and atezolizumab (branded as Tecentriq)– for …